Biovitrum: Partners wanted for early-stage primary care

Licensing opportunities

The biopharmaceutical  company Biovitrum of Stockholm, Sweden is restructuring its business and looking to out-license several early-stage research projects, primarily within diabetes and obesity. In total, ten projects are on offer at different stages preclinical development.

The company previously announced that it is looking for partners for two clinical Phase II projects, in neuropathic pain and glaucoma.